Eton Pharmaceuticals Inc (ETON)
Company Info
US29772L1089
29772L108
Nov 13, 2018
Highlights
$236.92M
-$0.26
$27.36M
$16.94M
-$2.70M
$3.03 - $17.80
$13.00
0.83%
0.95
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Eton Pharmaceuticals Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Eton Pharmaceuticals Inc had a return of 25.15% year-to-date (YTD) and 271.27% in the last 12 months.
ETON
25.15%
28.23%
373.58%
271.27%
19.76%
N/A
^GSPC (Benchmark)
1.92%
0.88%
15.58%
20.89%
12.50%
11.34%
Monthly Returns
The table below presents the monthly returns of ETON, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 32.73% | 25.15% | |||||||||||
| 2024 | 6.62% | -4.71% | -15.73% | -6.67% | 1.43% | -7.32% | 9.42% | 27.78% | 30.43% | 41.17% | 59.74% | -1.55% | 204.11% |
| 2023 | 23.40% | 7.18% | 3.22% | -5.71% | 9.09% | -11.87% | -19.20% | 59.57% | -7.33% | 1.20% | -16.11% | 23.73% | 55.32% |
| 2022 | -13.75% | 1.62% | 15.96% | -19.04% | -13.88% | -13.82% | 2.29% | -15.67% | -7.08% | 21.43% | 18.43% | -6.62% | -34.27% |
| 2021 | 9.72% | -11.32% | -7.46% | 18.58% | -18.66% | -12.75% | -16.56% | 2.53% | -4.36% | 14.29% | -32.29% | 10.00% | -47.23% |
| 2020 | -7.50% | -18.92% | -24.07% | 26.34% | -11.20% | 18.48% | 22.57% | 17.37% | 0.77% | -7.72% | 8.92% | 2.39% | 12.92% |
| 2019 | -0.33% | 30.16% | 0.76% | -8.00% | 10.05% | -2.47% | -22.91% | -8.21% | 13.06% | -5.85% | 7.56% | 12.50% | 17.65% |
| 2018 | 1.60% | -3.62% | -2.08% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 97, ETON is among the top 3% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Eton Pharmaceuticals Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eton Pharmaceuticals Inc was 79.94%, occurring on Oct 20, 2022. Recovery took 519 trading sessions.
The current Eton Pharmaceuticals Inc drawdown is 5.71%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -79.94% | Feb 18, 2021 | 423 | Oct 20, 2022 | 519 | Nov 13, 2024 | 942 |
| -67.13% | Jul 11, 2019 | 174 | Mar 18, 2020 | 128 | Sep 18, 2020 | 302 |
| -26.56% | Sep 21, 2020 | 12 | Oct 6, 2020 | 69 | Jan 14, 2021 | 81 |
| -16.21% | Jan 3, 2025 | 3 | Jan 7, 2025 | 7 | Jan 17, 2025 | 10 |
| -15.38% | May 29, 2019 | 19 | Jun 24, 2019 | 11 | Jul 10, 2019 | 30 |
Volatility
Volatility Chart
The current Eton Pharmaceuticals Inc volatility is 25.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Eton Pharmaceuticals Inc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |